Needham analyst Gerald Pascarelli lowered the firm’s price target on Vital Farms (VITL) to $13 from $20 and keeps a Buy rating on the shares after it’s Q1 earnings miss and guidance cut. Expectations were low headed into the quarter, though the results and reset to outlook came in much worse than feared, the analyst tells investors in a research note. This also marks the third straight negative revision for Vital, and at this stage, investor confidence is at a trough and will need to be rebuilt through sustained improvement in volume trends, the firm added.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VITL:
- Buy Rating Maintained as Depressed Sentiment, Cheaper Valuation and Turnaround Efforts Support Reduced $13 Price Target
- Short Report: Bearish bets on Vital Farms at record high
- Vital Farms downgraded to Market Perform from Outperform at William Blair
- Vital Farms price target lowered to $10 from $15 at Morgan Stanley
- Craig-Hallum downgrades Vital Farms to Hold after significant cut to outlook
